Understanding the role of the tumor microenvironment in carcinogenesis has reshaped cancer research. Events at both microscopic (molecular) and macroscopic (tissue) scales have been identified in engineered tumor microenvironments involving in vitro cultures, live tissue xenografts, and transgenic animals. However, these events have not been comprehensively observed under unperturbed (authentic) conditions free of exogenous labeling or genetic modification. The lack of a suitable imaging methodology has largely limited our understanding of the complex interrelations and possible causal links involved in carcinogenesis and metastasis within the tumor microenvironment. Using multicontrast nonlinear imaging, we visualize endogenous substances in rat and human mammary tumors through their intrinsic nonlinear optical properties, and simultaneously observe angiogenesis, extracellular matrix reorganization, and non-native cell recruitment. We find that all these macroscopic events in the tumor microenvironment require concurrent enrichment of specific extracellular vesicles and a metabolic switch toward biosynthesis. This concurrence at the microscopic scale provides not only new insights into carcinogenesis and metastasis but also a potentially new strategy for cancer diagnosis, surgery, and therapeutics.
- tumor microenvironment
- extracellular vesicle
The tumor microenvironment has been represented by a nonreductionist view of cancer (1), interactions at the tumor-host interface (2), a wound-healing analog of tumor development (3), the concept of “seed and soil” (4), the bipolar effects of stroma in the tumor “organ” (5), and the Darwinian (environmental) selection of metastatic tumor cells (4, 6). Signature events occurring in the tumor microenvironment include (i) recruitment or infiltration of non-native cells, such as immune inflammatory cells (7) and bone marrow–derived cells (8), and activation or alteration of fibroblasts (9) or other native cells for promotion of tumor malignancy and protection from immune attack; (ii) a mechanically reorganized extracellular matrix, including degraded basement membrane (10) and rearranged, cross-linked, or fibrotic collagen (11) for enhanced local invasion (12); (iii) angiogenesis (13, 14) and lymphangiogenesis (15) for primary tumor growth and subsequent metastasis; (iv) modulation of stroma by small (<1 μm) tumor-associated extracellular vesicles for preconditioning proliferation, invasion, and metastasis of tumor cells (16); and (v) a metabolic switch from energy production to biomass production (biosynthesis), that is, a reinterpreted Warburg effect that enriches amino acids, nucleotides, and fatty acids (17). The metabolic switch has long been masked in oxygen- and nutrient-rich tissue cultures and has therefore been treated as an adaption to the stressful tumor microenvironment (18). Each of these tumor microenvironment events has been investigated with exogenous molecular labeling probes to identify biomolecules of interest (rare signaling molecules or bulk substances) within biological samples (cell/tissue cultures, xenografts, dissected specimens, transgenic animals, cancer animal models, living subjects, etc.) under in vitro, ex vivo, intravital, or in vivo conditions (19, 20). However, the interrelation between the events at the macroscopic scale (i to iii) and microscopic scale (iv and v) remains elusive because of the lack of an imaging methodology to observe them in concert, in spatially resolved ways, and without perturbative labels.
Optical imaging can be a promising approach (21) to study this interrelation if molecular labeling agents, including genetic reporters that may affect the living system through genetic manipulation, are avoided to eliminate unexpected perturbations to the tumor microenvironment. In addition, to retain more authentic physiology during carcinogenesis, imaging should be performed in nonxenograft tissues and using a reflection mode (epi-)geometry so that these events can be potentially monitored in future clinical scenarios to evaluate therapeutic strategies (1–19). Along this path, linear microscopy techniques using photoacoustics (22) or optical frequency domain imaging (23) targeting single-photon absorption or scattering contrast have visualized angiogenesis and lymphangiogenesis. However, the desired high spatial resolution, free of exogenous labeling, is gained at the price of molecular specificity, which is crucial in the era of molecular oncology (19, 20). Alternatively, nonlinear microscopy targeting two-photon optical noncentrosymmetry contrast χ(2)SHG (24, 25) and three-photon excited autofluorescence contrast AF(3) (26, 27) has imaged reorganized collagen and intrinsic fluorophores, respectively. Similarly, nonlinear microscopy has further visualized tumor cells through two-photon excited autofluorescence contrast AF(2) (28) and blood cells/vessels through the molecular vibration contrast of coherent anti-Stokes Raman scattering (CARS) χ(3)CARS (29). Thus, previously used cell-tracking fluorescent proteins (25) and injected angiogenesis-revealing agents (30) may be avoided. In addition, the χ(3)CARS contrast and three-photon optical heterogeneity contrast χ(3)THG have revealed the metabolic alteration to lipid/protein ratio (31, 32) and the release of extracellular vesicles in tissue (33), respectively. By demonstrating the versatility of nonlinear microscopy, these scattered efforts encouraged us to develop a multicontrast (multimodal) nonlinear imaging platform (34) capable of collecting spatially coregistered images with different contrasts (figs. S1 and S2 and table S1). We recovered the molecular specificity and were able to simultaneously observe all tumor microenvironment events (i to v) in a well-established preclinical carcinogen-induced (nontransgenic) rat mammary tumor model (35). We seek to visualize the interrelations and spatial relationships among these events and document the unusual concurrence of extracellular vesicle enrichment and a metabolic switch that underlies important steps in early cancer development.
Multicontrast imaging of unperturbed tumor microenvironments
Mammary tumor microenvironments in a carcinogen-induced rat model were investigated by multicontrast nonlinear imaging in a 9-week longitudinal study (see Table 1 and Materials and Methods). For example, in week 7 of tumor development, largely different and orthogonalized contrasts can be obtained from the same focal plane of an ex vivo mammary tumor (Fig. 1 and fig. S2). In particular, each pair of contrasts from harmonic generation (Fig. 1A), autofluorescence (Fig. 1B), and molecular vibration (fig. S2, A and B; Raman response at xxxx cm−1 is abbreviated as Rxxxx hereafter) is orthogonal to each other, reflecting local optical structure, redox activity (28), and lipid-protein transition (31, 32), respectively. The substances selectively revealed (or “artificially labeled”) by one contrast (fig. S2, A to F), when placed against the “background” of the other contrasts (fig. S2, A to L), allow unambiguous recognition of various macroscopic structures or events (Fig. 1) and new functional knowledge that is largely absent in lower dimensional multicontrast images (table S2), just as with conventional fluorescence-labeled imaging.
The light excitation/detection switched among χ(2)SHG, χ(3)THG, AF(2), AF(3), χ(3)R2850, and χ(3)R3050 plays an analogous role to six exogenous fluorescent dyes but with no known perturbation to the structure, molecular composition, or function of the biological sample. This results in the marked emergence of many micrometer-sized AF(3)-visible vesicles from AF(2)-visible vascular features during the transition from the AF(2) image to the AF(3) image (Fig. 1B and fig. S2E). Other classes of micrometer-sized vesicles (table S3), including lipid vesicles and χ(3)THG-AF(3)–covisible vesicles, are observed to be coregistered in images based on multiple different contrasts (fig. S2, A to F). This cross-contrast visibility provides independent confirmation and classification of spatially disorganized vesicles without sample motion artifacts, allows automatic identification of their locations and distributions by straightforward image processing, and validates the coregistered multicontrast imaging at the same imaging plane. Our ability to observe a wide variety of endogenous vesicles in the tumor microenvironments will facilitate future studies on their physiochemical properties and biological functions.
In addition to palpable tumors at a late stage (weeks 3 to 9) of tumor development, four additional types of samples were also imaged (Table 1): (i) “control” mammary specimens from rats without carcinogen injection, (ii) “normal” samples defined as the normal-appearing mammary tissue in early-stage (weeks 1 and 2) tumor development, free of palpable tumors or 10 mm away from palpable tumors in late-stage tumor development, (iii) “temporally precancerous” samples free of palpable tumors but suspicious of early-stage cancer development by visual (gross) inspection, and (iv) “spatially precancerous” samples resected 2 to 5 mm away from palpable tumors suspicious of precancerous development by visual inspection. The typical field of view of nontumor (control or normal) samples consists of approximately 80% adipocyte-dominated regions (Fig. 2, main) with 20% stromal regions (Fig. 2, insets 1 and 2). The extensive image analysis of tumor and nontumor samples enables the differentiation of observed macroscopic tumor microenvironment events (7–15) from certain nontumor macroscopic events (table S4), as discussed below.
Extracellular vesicle enrichment in stroma
The χ(3)THG-AF(3)–covisible vesicles are obscured by a strong AF(2) background in Fig. 1 but revealed in the χ(3)THG image of fig. S2F. These vesicles reside in certain AF(2)-visible cells (colocalized red arrows in Fig. 1, A and B) and are released into various stromal regions with thin elastin fibers, dense collagen, angiogenesis, and lipid breakdown (fig. S2F). Moreover, except for two samples from a necrotic tumor and another sample from an abnormal control rat (7_control/b in Table 1A), these vesicles are systematically more abundant in tumors than in nontumor samples, with little dependence on sample spatial heterogeneity (Table 1A). Thus, we attribute the χ(3)THG-AF(3)–covisible vesicles to tumor-associated extracellular vesicles likely originating from the tumor cells at the tumor boundary (Fig. 1, A and B). The otherwise normal adipocytes [with AF(2)-visible cytoplasm located at interstitial spaces among large lipids] and stromal cells free of these vesicles (pink arrows in Fig. 2) seem to transform by accepting and concentrating the vesicles (Fig. 1, A and B; malignant adipocytes or stromal cells). It appears that the stroma is modulated by these vesicles during carcinogenesis (16).
These extracellular vesicles cannot be discriminated against the “benign” χ(3)R2850-χ(3)THG–covisible lipid vesicles (29, 36) by χ(3)THG contrast alone but disappear from the χ(3)THG image when the contrast is instantly switched to χ(3)R2850 (compare fig. S2F with fig. S2B). This discrimination strategy, termed as “tracking disappearances in a different light” (as opposed to “seeing things in a different light” exhibited by fig. S2, A to F), sets our assignment apart from the previous study that assigned all χ(3)THG-visible vesicles as tumor-associated extracellular vesicles (33). The interfering lipid vesicles can migrate to the extracellular stromal regions of collagen fibers (Fig. 2, inset 1; termed as “stromal lipid dispersion” in table S4) but exhibit no disparate prevalence in tumor and nontumor samples. They would thus mask the key statistical evidence that identifies the tumor-associated extracellular vesicles (Table 1A).
(Lymph-)angiogenesis and extracellular matrix reorganization
The observed AF(3)-visible vesicles appear related to the blood vessels during angiogenesis. Using their density to estimate the stages of angiogenesis (Fig. 1), we can classify the observed vessels or capillaries as (i) developed vessels with less or no vesicles but a χ(3)R2850-AF(2)–covisible vessel wall, (ii) developing vessels with more vesicles and a high internal AF(2) signal but no detectable vessel wall, and (iii) emerging vessels with abundant vesicles but neither a high internal AF(2) signal nor a well-defined vessel wall. The hyperspectral imaging of χ(3)CARS (see Materials and Methods) confirms a developing blood vessel by revealing its internal flow (movie S1). Another category of vessels with larger diameters and poorly organized (leaky) AF(2)-visible walls may be attributed to lymphatic vessels because they do not have the continuous χ(3)R2850-visible vessel wall characteristic of the developed blood vessels (29). These lymphatic vessels can be similarly classified as developing vessels that have the AF(3)-visible vesicles and developed vessels free of these vesicles (Fig. 1). The same type of vesicles appears to initiate both angiogenesis and lymphangiogenesis.
We therefore used this vesicle reporter, rather than the established external labeling that may perturb the tumor microenvironment (37), to visualize (lymph-)angiogenesis throughout our longitudinal study. It should be noted that the observed angiogenesis in ex vivo tissue seems to be rather different from the classic sprouting mechanism of angiogenesis observed in vitro (38). (Lymph-)angiogenesis was widely observed in tumors but was largely absent in nontumor samples (Table 1), except for two samples from the abnormal control rat that seemed to undergo spontaneous angiogenesis (Fig. 3A and 7_control/b in Table 1A) and lymphangiogenesis (Fig. 3B and 7_control/a in Table 1A). The corresponding histopathology confirmed that this abnormal control rat developed breast cancer spontaneously without carcinogen injection.
Degradation of basement membrane is required for tumor invasion, proliferation, and metastasis (10), and it may be present around blood vessels (Fig. 3B) and lymphatic vessels or mammary ducts/lobules (Fig. 3C). As expected, the basement membrane degradation is absent in nontumor samples (Table 1). In addition to the basement membrane degradation, another form of extracellular matrix reorganization is associated with χ(2)SHG-visible collagen. Tubular collagen reorganization to accommodate angiogenesis can be found at different stages of angiogenesis (Fig. 1A and fig. S2I). In addition, dense collagen known as fibrosis can form in concert with (lymph-)angiogenesis (Fig. 1A) (11, 12).
Fibroblast activation and non-native cell recruitment
An isolated (malignant) cell can be typically recognized as having AF(2)-visible (flavin adenine dinucleotide–rich) cytoplasm and a void of optical signal from the nucleus (Figs. 1B, 2B, and 3B) (28). Regular collagen production can be recognized from the composite AF(2)-χ(2)SHG image, in which χ(2)SHG-visible collagen fibers are generated along the elongated directions of AF(2)-visible fibroblasts (table S4). This dual-contrast imaging can visualize fibroblasts without (frequently unspecific) external markers (9). Rather strikingly, the collagen production may be accompanied by the AF(3)-visible angiogenesis along the same directions (Fig. 3D), confirming the role of fibroblast activation in stimulating angiogenesis in tumor development (9). The fibroblast activation may have also induced fibrosis in the same field of view (Fig. 3D).
AF(2)-visible χ(3)THG-invisible cells, other than the fibroblasts, can be found in nontumor samples and tumors (for example, Figs. 1B and 3E) and are therefore termed generally as native cells. Some cells with high χ(3)THG contrast but low AF(2) emerge along with the native cells in the AF(2)-χ(3)THG image of a tumor (Fig. 3E). Similar χ(3)THG-visible cells can be found in the sample undergoing spontaneous carcinogenesis (Fig. 3, A and B) and other tumor samples (for example, Fig. 3C), but not in nontumor samples (table S4). Thus, these cells are not native to the normal mammary gland and can be treated as a cancer indicator. This observation is consistent with the recruitment of non-native immune cells (7) or bone marrow–derived cells (8) in carcinogenesis.
Metabolic switch identified by in situ chemical analysis
Lipolysis and lipid breakdown result in a lipid-protein/water transition that decreases lipid content and increases protein/water content (table S4). They can be recognized in the hyperspectral χ(3)CARS image stack that consists of a sequence of χ(3)CARS images, in which each pixel reflects an entire χ(3)CARS spectrum that indicates chemical content in situ (Figs. 1D, 2D, and 4D) (31, 39). Altered metabolism along the lipid-protein/water transition, which manifests itself as an elevated ratio of χ(3)R2930/χ(3)R2850, has been used to detect the tumor margin of breast cancer (31) and brain cancer (32). Similar ratiometric indicators have been widely used in diagnostic Raman spectroscopy. However, it should be noted that this ratio alone is not a reliable cancer indicator because the lipolysis and lipid breakdown that elevate this ratio are not specific to tumors (Figs. 1D, 2D, and 4D and table S4). In particular, the nonadipocyte stromal regions (Fig. 2, insets 1 and 2) that occupy ~20% of the field of view of nontumor samples (Fig. 2, main) have a high ratio and may thus be mistakenly treated as tumorous regions.
In contrast, a closely related on-and-off (nonratiometric) cancer indicator can be found within the detectable CH-stretch Raman range across R2550-R3250. Except for the regions of adipocytes free of the lipid-protein/water transition (cyan curves in upper panels of Figs. 1D, 2D, and 4D⇑), this indicator presents as an emergent R3050 peak in the χ(3)CARS spectra of tumor or precancerous samples, but not in nontumor samples, independent of the sampling location (pixel) of the in situ chemical analysis (Figs. 1D, 2D, and 4D). For example, the protein-rich cells (or mammary duct wall) in the spatially precancerous sample of Fig. 4 (main or inset 2) can be discriminated against their counterparts in the nontumor sample of Fig. 2 (main or inset 2) by simply detecting this R3050 peak (Figs. 2D and 4D, lower panels). The same biomarker has also differentiated other features with varying degrees of lipid-protein/water transition (deformed adipocytes, lipid droplets, peripheral nerves, vasculature walls or boundaries, fibroblasts, collagen-rich stromal regions, stromal fluids, etc.) in the tumor and (temporally or spatially) precancerous samples from their nontumor counterparts (Table 1A).
The R3050 peak is present in tumor-specific regions of fibrosis (Fig. 1D, lower panel) and (lymph-)angiogenesis that are rich in protein and water and also in skin and muscle specimens resected from the control animals, suggesting that up-regulated water-soluble molecules from biosynthesis (for example, amino acids, peptides, and low–molecular weight proteins) are responsible for this spectral peak. Consistently, the R3050 peak disappears whenever biosynthesis-inactive large lipid droplets are probed (Fig. 1D, upper panel) or when tumor cells undergo necrosis with no active biosynthesis (Table 1A). Thus, the emergence of the R3050 peak reflects a metabolic switch from an energy-storing phenotype of normal mammary gland to a biosynthesis phenotype found in regular skin and muscle (17). In comparison to other animal cancer models of skin or other biosynthesis-active organs, the unique absence of the biosynthesis phenotype in prepuberty mammary gland (our selected animal model) enables sensitive detection of this metabolic switch.
Interrelated microscopic and macroscopic events in the tumor microenvironment
With the simultaneous observation of macroscopic and microscopic tumor microenvironment events (7–17) in tumors and precancerous samples (Table 1), it is now possible to investigate their interrelationships in this longitudinal study. Once a cutoff density of tumor-associated extracellular vesicles (six per field of view) is chosen to differentiate tumor/precancerous samples from nontumor samples, this vesicle-based cancer indicator and the R3050 biomarker become self-consistent (Table 1A). The two microscopic events (extracellular vesicle enrichment and metabolic switch) cross-validate one another and assert quantitatively that the two temporally precancerous samples and six spatially precancerous samples from carcinogen-injected rats that appear uncertain on visual inspection (“+/−” in Table 1A) are in early stages of carcinogenesis. A spectroscopic cancer indicator, such as the R3050 biomarker, may be of clinical significance during intraoperative surgery, in which visual inspection could be unreliable (32).
Throughout tumor development before necrosis, at least one of the three macroscopic tumor microenvironment events was observed in 13 of 15 tumor samples, but in 0 of 6 spatially precancerous samples and 0 of 2 temporally precancerous samples (Table 1A). Because the two microscopic tumor microenvironment events were universally observed in these samples, in contrast to the nontumor samples, the disparate distribution of the macroscopic events in the tumor and precancerous samples (for example, compare Fig. 4 with Fig. 1) strongly suggests a causal relation from the microscopic events to the macroscopic events. That is, the extracellular vesicle enrichment and metabolic switch may directly cause the subsequent large-scale changes of non-native cell recruitment or fibroblast activation, extracellular matrix reorganization, and (lymph-)angiogenesis. The only exception to this hypothesis is the unique sample from the abnormal control rat (7_control/b in Table 1A), which showed that angiogenesis preceded the two microscopic events. We speculate that this natural angiogenesis provided a favorable environment to induce the two microscopic events revealed in another sampling site (7_control/a in Table 1A) and subsequently cause spontaneous carcinogenesis. Except for this nontrivial sample and two trivial samples with necrosis, there is a full agreement between the two cross-validated cancer indicators and visual inspection (Table 1A).
Because of the known extracellular communication functions of extracellular vesicles (40), the possible sequence of the observed events is as follows: (i) sparse tumor cells release the extracellular vesicles to modulate their surrounding microenvironment inside the mammary organ; (ii) numerous fibroblasts, adipocytes, and other native cells accept the vesicles and switch their metabolism from energy production and storage to biosynthesis; (iii) the metabolic switch induces the non-native cell recruitment, extracellular matrix reorganization, and (lymph-)angiogenesis to produce the tumor microenvironment we currently understand (7–15).
Applicability to human breast cancer
Because no specific sample treatment is required for these investigations, we readily imaged fresh sections of human breast cancer to detect the tumor-associated extracellular vesicles. Various vesicles were found in a biopsied specimen of human breast tumor with prominent lipolysis (Fig. 5A) and can be classified into three distinct classes with different cross-contrast visibility (Fig. 5B). The in situ chemical analysis indicates that one class of eight χ(3)THG-AF(3)–covisible vesicles have a protein-like spectrum (Fig. 5C) similar to the spectrum of their rat counterparts and are absent in the normal tissue from the same patient (fig. S3). The other two classes, including one with 173 AF(2)-AF(3)–covisible vesicles, have strong AF(2) signals and lipid-like spectra (Fig. 5D). They are likely derived from the lipids of adipocytes (for example, area β; Fig. 5A). Because the spectrum of either class of vesicles approximates that of the surrounding interstitial fluid (area α; Fig. 5A), they are χ(3)CARS-invisible due to low contrast. Despite this invisibility, the cross-contrast imaging beyond χ(3)CARS allows in situ chemical analysis to discriminate between the two. Thus, the three classes of vesicles found in the human breast cancer tissue can all be correlated with those found in the rat mammary tumors (table S3). These results reinforce the applicability of vesicle-based cancer indicators in human breast cancer. More detailed studies are needed to determine whether this vesicle enrichment is a more universal process in the early development of other cancers as well (41).
The metabolic switch toward biosynthesis (17) is typically treated as an adaptation to a stressed tumor microenvironment (18), that is, a consequence of macroscopic events such as the extracellular matrix reorganization. Somewhat surprisingly, the evidence provided here suggests that this metabolic switch occurs in both temporally and spatially precancerous samples and can precede extracellular matrix reorganization and other macroscopic events in the tumor microenvironment. The observation of the metabolic switch during the earliest stages of tumor development reinforces the notion to classify it as an emerging hallmark of cancer (42).
The in vivo role of extracellular vesicles has been relatively elusive without observing them label-free in tissue. By visualizing these vesicles in situ in the unperturbed tumor microenvironment, we have found a direct link between their enrichment and the metabolic switch toward biosynthesis. Thus, these vesicles may serve as the signaling mediators from the tumor cells to the abundant stromal cells to initiate the metabolic switch, which may, in turn, induce various macroscopic events in the tumor microenvironment. Genetic modification of the stromal cells can occur when they accept the vesicles with RNA (43). These observations establish the extracellular vesicle enrichment as a fundamental tumor microenvironment event worthy of further investigation.
Both the metabolic switch and the extracellular vesicle enrichment are microscopic events in the tumor microenvironment and are independent of the macroscopic heterogeneity of the sample. This aspect, together with their concurrence at the earliest stages of tumor development, may qualify them as more effective targets for cancer diagnosis and therapeutic intervention (16, 17) than the subsequent macroscopic events. Their concurrence in the precancerous regions may have clinical significance during intraoperative procedures, suggesting that the tumor margin may actually lie well beyond the visually delineated structural tumor boundary that is currently defined histologically.
We note that the major conclusions in this study are drawn from a rather small-scale animal study. In addition, the applicability to human study has been limited to a few specimens. The recognition of various macroscopic tumor microenvironment events is based on morphological features and therefore subjective to interobserver variations. These limitations can be overcome by future large-scale animal and human studies and the development of machine learning procedures to automatically recognize the events.
The simultaneous observation of both microscopic and macroscopic events in these unperturbed tumor microenvironments highlights the advantage of our multicontrast imaging methodology in cancer research and for future assessment of therapeutic strategies. These complex events in carcinogenesis and metastasis could not be easily detected if investigated by only one individual contrast mechanism or imaging modality, or with a lower dimension of combined contrast mechanisms. With these multiple contrasts, malignant cells and angiogenic vessels can be respectively “labeled” by intrinsic tumor-associated vesicles and tubularly aligned vesicles to differentiate them from normal cells and regular blood vessels. A wide variety of other features in carcinogenesis can also be similarly identified. The use of more invasive exogenous labeling, specific sample treatment, and genetic modification are no longer required to attain this level of imaging so that any associated artifacts are avoided. This investigational approach and visualization methodology is possible in the unperturbed tumor microenvironment, enabling the study of the complex dynamics and spatially and temporally resolved characteristics of tumor cells and tumor-associated extracellular vesicles, with future applications in in vivo preclinical animal tumor models and in clinical human studies.
MATERIALS AND METHODS
Animal and human tissues
Animal procedures were conducted under a protocol approved by the Institutional Animal Care and Use Committee at the University of Illinois Urbana-Champaign. A total of 20 female rats (F344, Harlan) were included in the study, with 10 carcinogen-injected and 10 control animals. Mammary tumors were induced in 7-week-old rats by intraperitoneal injection of N-nitroso-N-methylurea (NMU; Sigma-Aldrich) at a concentration of 55 mg/kg. The first injection was administered on the left abdominal side, followed by a second injection 1 week later on the right abdominal side. This NMU-induced rat mammary tumor model is well established and particularly suitable for investigating breast cancer development because the anatomical and pathological features, the hormone dependency, and the immunohistochemical responses of the lesions mimic human ductal carcinoma in situ (44–46). The tumors were first palpable from the abdominal surface approximately 4 weeks after the second injection (Table 1). For the control group, an equal amount of saline was injected to account for any effects from the injection alone. The rats from both groups were euthanized 1 to 9 weeks after the second injection (Table 1). Mammary tissue was dissected and placed in saline at 4°C before imaging within 12 hours.
Human tissue was obtained under a protocol approved by the institutional review boards at the University of Illinois at Urbana-Champaign and Carle Foundation Hospital. After surgical removal, excess cancerous and normal breast tissue from a patient was stored in saline-filled conical tubes and transported on ice for imaging within 12 hours.
Pulse-shaping multiphoton microscope
The short-wavelength edge of the generated supercontinuum (780 to 880 nm) (47) was reflected by a dichroic mirror (DMLP900, Thorlabs) as the pump beam for CARS, whereas the main supercontinuum (900 to 1300 nm) was sent into a commercial pulse shaper as the CARS Stokes beam or the excitation beam to generate the contrast from AF(2), AF(3), χ(2)SHG, or χ(3)THG (fig. S1). The Stokes beam was optically delayed by a computer-controlled delay line to realize spectral focusing CARS (48) and collect the vibrational contrast of χ(3)CARS. Two SF57 glass blocks were placed in the pump/Stokes beams to prechirp the pulses. The two beams were then recombined by another dichroic mirror, steered into a commercial microscope (BX61WI, Olympus), and focused by a super-apochromat objective (UPLSAPO 60×W/IR; numerical aperture, 1.20; Olympus). In AF(2)/AF(3)/χ(2)SHG/χ(3)THG imaging, the CARS pump beam was blocked by a computer-controlled shutter (fig. S1). A pixelated 4f pulse shaper (MIIPS Box640, Biophotonic Solutions) was used to iteratively compress the supercontinuum pulse, whereas the pulse measurement based on multiphoton intrapulse interference phase scans (MIIPS) (49) was used in the iteration loop. The coherence of the supercontinuum was validated by the converged iteration toward transform-limited pulse compression. The technique of “local compression” (47) was used to generate tunable ~30-fs pulses across the bandwidth of the supercontinuum. After the transform-limited pulse compression, the pulses were programmed for customized multiphoton imaging modalities.
Label-free nonlinear optical imaging with multiple contrasts
The excitation pulses customized for the multiple imaging modalities were amplitude/phase-shaped from the supercontinuum and paired with various detection filters to target different endogenous molecules or structures of interest. The incident power of the phase-shaped supercontinuum pulses was attenuated by amplitude shaping to conservatively safe levels (table S1) so that no sample damage was observed and the same sample could be repeatedly imaged by different modalities. To validate the multiphoton imaging modalities, we performed power dependence tests for each modality with the unstained cancerous and normal rat mammary tissue. Images (380 × 380 pixels, 0.5 × 0.5 μm2 per pixel) were acquired with different average powers, and the average intensity (photon counts) was calculated and plotted against excitation average powers on double logarithmic scales. The linearly fitted slopes were consistent with the quadratic power dependence for AF(2) and χ(2)SHG, the cubic power dependence for AF(3) and χ(3)THG, and the quadratic/linear power dependence in pump/Stokes for χ(3)CARS. The small deviation from the theoretical numbers (<10%) might be due to the diverse biomolecular composition of the tissue samples, excitation/emission cross-talk, and low or saturated signal within the field of view.
Image acquisition was performed by raster scanning a piezoelectric stage with a pixel dwell time of 200 μs for all modalities. To generate a strong and high–spectral resolution χ(3)CARS signal, the spectrally dispersive power of the supercontinuum was concentrated into a single vibrational frequency by spectral focusing, in which both the pump and Stokes pulses were chirped so that their instantaneous frequency difference remained the same during their interaction time to coherently drive one molecular vibration (48). Spectroscopic acquisition was achieved by scanning the delay between two pulses to tune the frequency difference with a spectral resolution of 14 cm−1, which was calculated from the measured FWHM (19 cm−1) of the 2913-cm−1 peak in the χ(3)CARS spectrum of dimethyl sulfoxide. This spectral-focusing CARS was used to collect hyperspectral CARS images from the biological samples, each of which was obtained at one Raman vibration frequency that was varied among the images. The χ(3)CARS spectrum at an arbitrarily selected region of interest was calculated from these images over the corresponding pixels. The χ(3)CARS spectrum from a single-pixel adipocyte region in a normal human breast tissue approximated that of a larger 500-pixel adipocyte region with sufficient signal-to-noise ratio (fig. S3). Similar calculations were used to obtain the local χ(3)CARS spectra in other features. In both human and animal tissues, a thick section was placed on a microscope slide and sealed under a coverslip. The imaging focal plane was placed ~10 μm below the sample surface.
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/full/3/1/e1600675/DC1
table S1. Multicontrast nonlinear imaging to observe various tumor microenvironment events.
table S2. New knowledge acquisition by dimension-increased multicontrast image analysis of a rat mammary tumor.
table S3. Observed micrometer-sized vesicles in mammary tissue classified by cross-contrast visibility and chemical content.
table S4. Macroscopic events observed in tumor microenvironments and in nontumor mammary samples.
fig. S1. Schematic for label-free multicontrast nonlinear imaging.
fig. S2. Coregistered multicontrast images of an unperturbed mammary tumor from a carcinogen-injected rat.
fig. S3. Coregistered single-contrast images of an unperturbed normal human mammary specimen.
movie S1. Sweeping of hyperspectral χ(3)CARS images from the middle-right corner of Fig. 1C.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
REFERENCES AND NOTES
- Copyright © 2017, The Authors